| Bioactivity | Levonadifloxacin ((S)-(-)-Nadifloxacin; WCK 771) is a broad-spectrum anti-staphylococcal agent. Levonadifloxacin shows antibacterial activity against Methicillin (HY-121544)-susceptible Staphylococcus aureus (MSSA) and Methicillin-resistant S. aureus (MRSA) strains, with a reduction of which phagocytized in THP-1 monocytes[1]. | ||||||||||||
| Invitro | Levonadifloxacin (32 μg/mL; 24 h) achieves a 90-99% intracellular reduction of MSSA and MRSA strains phagocytized in THP-1 monocytes with MICs of 0.03 μg/mL and 15.0 ng/mL[1]. | ||||||||||||
| Name | Levonadifloxacin | ||||||||||||
| CAS | 154357-42-3 | ||||||||||||
| Formula | C19H21FN2O4 | ||||||||||||
| Molar Mass | 360.38 | ||||||||||||
| Transport | Room temperature in continental US; may vary elsewhere. | ||||||||||||
| Storage |
|
Levonadifloxacin
CAS: 154357-42-3 F: C19H21FN2O4 W: 360.38
Levonadifloxacin ((S)-(-)-Nadifloxacin; WCK 771) is a broad-spectrum anti-staphylococcal agent. Levonadifloxacin shows a
Data collection：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.